Table 1.
Baseline information.
| IVC+PRP (n = 50) | PRP (n = 32) | t,χ2 | P | |
|---|---|---|---|---|
| Sex, n (%) | ||||
| Male | 26 (52.0%) | 16 (50.0%) | 0.03 | 0.86 |
| Female | 24 (48.0%) | 16 (50.0%) | ||
| Age (years) | 62.12 ± 5.37 | 63.86 ± 6.03 | 1.37 | 0.18 |
| Eyes | ||||
| Right eye | 27 (54.0%) | 15 (46.9%) | 0.40 | 0.53 |
| Left eye | 23 (46.0%) | 17 (53.1%) | ||
| BCVA (LogMAR) | 0.65 ± 0.15 | 0.46 ± 0.13 | 5.97 | < 0.01 |
| CFT (μm) | 470.91 ± 44.14 | 295.43 ± 32.09 | 19.43 | < 0.01 |
| Duration of diabetes (years) | 6.66 ± 2.14 | 7.58 ± 1.73 | 2.04 | 0.04 |
BCVA, best-corrected visual acuity; CFT, central foveal thickness.